HistoSonics reported the successful treatment of the first patients in WOLVERINE, a new trial evaluating the Edison ...
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...
HistoSonics announced the first successful treatments in a study of its Edison histotripsy system for benign prostatic hyperplasia (BPH).
World’s first robotic Prostatic Artery Embolization (PAE) for Benign Prostatic Hyperplasia (BPH) and robotic Y-90 radioembolization mapping for ...
CINCINNATI (WKRC) — A groundbreaking procedure is offering new hope for men suffering from benign prostate hyperplasia (BPH), a condition affecting up to half of all men. Keith Neer, a patient who ...
Profound Medical Corp. (NASDAQ:PROF) is one of the best Canadian stocks with huge upside potential. On June 10, Profound Medical announced the successful completion of the first commercial benign ...
Introduction: Thulium laser enucleation of the prostate (ThuLEP) and bipolar transurethral resection of the prostate (bipolar TURP) are established surgical therapy alternatives that have proved ...
DEAR MAYO CLINIC: Recently, I was diagnosed with BPH. This is all new to me, and I hope you can help me better understand the condition and how it's treated. ANSWER: Now that you've been diagnosed ...
If urinary symptoms are affecting you, consult a urologist to explore advanced, minimally invasive treatments like Prostatic Urethral Lift (UroLift). Today's BPH treatments are designed to relieve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results